Is 2.5 mg of tirzepatide the same as 50 units?

Only at 5 mg/mL. Units measure volume, not drug, so the same 2.5 mg is 31.25 units at 8 mg/mL, 25 units at 10 mg/mL, 16.67 units at 15 mg/mL and 12.5 units at 20 mg/mL on a U-100 insulin syringe. Check the strength printed on your vial label before you count units. Not personalized advice; confirm your dose, in mg and in units, with your prescriber or the dispensing pharmacy.

How many mL is 2.5 mg of tirzepatide?

2.5 mg ÷ the vial strength = mL: 0.5 mL at 5 mg/mL, 0.3125 mL at 8 mg/mL, 0.25 mL at 10 mg/mL, 0.1667 mL at 15 mg/mL, 0.125 mL at 20 mg/mL. On a U-100 syringe, every 0.01 mL is 1 unit.

Can 2.5 mg of tirzepatide be measured on an insulin syringe?

At 5 mg/mL it is 50 units, which fits a 0.5 mL (50 units) syringe; at 8 mg/mL it is 31.25 units, which fits a 0.5 mL (50 units) syringe; at 10 mg/mL it is 25 units, which fits a 0.3 mL (30 units) syringe; at 15 mg/mL it is 16.67 units, which fits a 0.3 mL (30 units) syringe; at 20 mg/mL it is 12.5 units, which fits a 0.3 mL (30 units) syringe. At 8 mg/mL and 15 mg/mL the volume does not land on a printed mark, even on a half-unit scale, so ask the prescriber or pharmacy how they want it measured.

How Many Units Is 2.5 mg of Tirzepatide? U-100 Chart

Short answer: 2.5 mg of tirzepatide is 50 units on a U-100 syringe at 5 mg/mL, 31.25 units at 8 mg/mL, 25 units at 10 mg/mL, 16.67 units at 15 mg/mL and 12.5 units at 20 mg/mL. In volume that is 0.5 mL at 5 mg/mL, 0.3125 mL at 8 mg/mL, 0.25 mL at 10 mg/mL, 0.1667 mL at 15 mg/mL and 0.125 mL at 20 mg/mL. Compounded products are not FDA approved; check the strength on your vial label, because the units are only right for that strength.

Compounded vs FDA-approved. Compounded tirzepatide is not FDA approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold (FDA). Mounjaro and Zepbound single-dose pens each hold one fixed dose, and the KwikPen is set to its labeled dose, so the dose is chosen in mg and there are no syringe units to work out. The labeled single-dose vials are one dose each, and the labeled multi-dose vial gives four doses of 0.6 mL; follow the instructions for use that come with them, not a compounded units chart.

How many units is 2.5 mg at each vial strength?

Each row converts 2.5 mg at one compounded tirzepatide strength for a U-100 insulin syringe (1 mL = 100 units). Not personalized advice; confirm your dose, in mg and in units, with your prescriber or the dispensing pharmacy.

2.5 mg of tirzepatide, U-100 insulin syringe. Click a strength for every dose at that strength.
Vial strength	Volume	U-100 units	Smallest syringe that holds it
5 mg/mL	0.5 mL	50 units	0.5 mL (50 units)
8 mg/mL	0.3125 mL	31.25 units (between marks)	0.5 mL (50 units)
10 mg/mL	0.25 mL	25 units	0.3 mL (30 units)
15 mg/mL	0.1667 mL	16.67 units (between marks)	0.3 mL (30 units)
20 mg/mL	0.125 mL	12.5 units	0.3 mL (30 units)

"Between marks" means the volume does not land on a printed line, even on a 0.3 mL syringe with half-unit markings. See U-40 vs U-100 syringes and how to read the marks.

How do you check the math?

Divide the dose by the strength to get mL, then multiply by 100 for U-100 units. To check, run it backwards: units ÷ 100 × mg/mL should give back 2.5 mg.

5 mg/mL. 2.5 mg ÷ 5 mg/mL = 0.5 mL × 100 = 50 units; check: 50 ÷ 100 × 5 = 2.5 mg
8 mg/mL. 2.5 mg ÷ 8 mg/mL = 0.3125 mL × 100 = 31.25 units; check: 31.25 ÷ 100 × 8 = 2.5 mg
10 mg/mL. 2.5 mg ÷ 10 mg/mL = 0.25 mL × 100 = 25 units; check: 25 ÷ 100 × 10 = 2.5 mg
15 mg/mL. 2.5 mg ÷ 15 mg/mL = 0.1667 mL × 100 = 16.67 units; check: 16.67 ÷ 100 × 15 = about 2.5 mg
20 mg/mL. 2.5 mg ÷ 20 mg/mL = 0.125 mL × 100 = 12.5 units; check: 12.5 ÷ 100 × 20 = 2.5 mg

If the units on your instructions do not match this math for the strength on your vial, ask the prescriber or pharmacy before injecting.

Where is 2.5 mg in the label schedule?

In the Mounjaro label, 2.5 mg is dose step 1 of 6. The label schedule lists it as Start: 2.5 mg once weekly. (Mounjaro label)

In the Zepbound label, 2.5 mg is dose step 1 of 6. The label schedule lists it as Weeks 1 to 4: 2.5 mg once weekly (for starting treatment only). The label also says: The label states that 2.5 mg is for starting treatment and is not an approved maintenance dose. (Zepbound label)

Compounded tirzepatide has no FDA label of its own. For reference, these are the schedules in the FDA labels that name 2.5 mg, with its rows highlighted.

Zepbound (FDA label, section 2)

Label schedule, quoted from the prescribing information. Your prescriber sets your own schedule.
When	Label dose
Weeks 1 to 4	2.5 mg once weekly (for starting treatment only)
Week 5	5 mg once weekly
Further steps	Increase by 2.5 mg after at least 4 weeks on the current dose
Maintenance	5 mg, 10 mg or 15 mg once weekly for weight reduction; 10 mg or 15 mg for obstructive sleep apnea
Maximum	15 mg once weekly

The label states that 2.5 mg is for starting treatment and is not an approved maintenance dose.

Mounjaro (FDA label, section 2)

Label schedule, quoted from the prescribing information. Your prescriber sets your own schedule.
When	Label dose
Start	2.5 mg once weekly
Further steps	If more glycemic control is needed, increase by 2.5 mg after at least 4 weeks on the current dose
Maximum	15 mg once weekly in adults

For pediatric patients 10 years and older the Mounjaro label sets a lower maximum of 10 mg once weekly.

Full schedules: Mounjaro dosing schedule · Zepbound dosing schedule

Other tirzepatide doses

Next step: 5 mg

5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg · All tirzepatide doses and strengths in one grid

Mixing a powder vial instead? The tirzepatide reconstitution guide and the free reconstitution calculator handle vials you add water to.

How many units is 2.5 mg of tirzepatide?